LUCD (Lucid Diagnostics, Inc.) Volume dana dhuwit perusahaan

Lucid Diagnostics Inc. - logo grafis emiten LUCD

The non-cyclical nature of cancer diagnostics guarantees stable demand, as confirmed by the base chart on GURU.Markets: the cash balance has reached the 0.02 parameter. The eco-friendliness of the methods reduces hazardous waste, while the uniqueness of the tests ensures significant pricing power. The liquid reserves of Lucid Diagnostics Inc. (LUCD) demonstrate the company's resilience, allowing for confident business development even amidst revenue volatility.

LUCD - Aset likuid perusahaan Lucid Diagnostics, Inc. ing rentang 04.07.2022 - 21.11.2026

LUCD (Lucid Diagnostics, Inc.): rincian analitis lan laporan miturut indikator

Ringkesan analitik perusahaan:LUCD Lucid Diagnostics, Inc.
Produk merek Lucid Diagnostics

The steady expansion of cancer marker screening capacities requires a constant influx of capital for equipment modernization for Lucid Diagnostics Inc. (LUCD). The dynamics of the cash balance demonstrate the volume of liquid assets available for operational management without resorting to external loans. This metric measures the issuer's ability to independently cover cash gaps and service debt obligations. For the investor, this balance defines the tipping point between financial stability and capital efficiency.

Pesaing Lucid Diagnostics Inc. (LUCD)

Dhuwit awis perusahaan A (Agilent Tech)|Quest Diagnostics - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Illumina Corp ILMN|Aset likuid perusahaan Exact Sciences Corporation (EXAS)|RVTY: Dhuwit awis perusahaan|BIO: Dana dhuwit perusahaan|Anbio Biotechnology Ltd (NNNN) - Dana dhuwit perusahaan|soterahealth.com (SHC) - Volume dana dhuwit perusahaan|QDEL (QuidelOrtho Corporation) - Volume dana dhuwit perusahaan|OPK: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan CDNA|MRVI: Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan FLGT (Fulgent Genetics Inc)|Gunggung dana dhuwit perusahaan LAB (fluidigm.com)|Cytek Corp - Volume dana dhuwit perusahaan|OSUR (OraSure Technologies, Inc.) - Dhuwit awis lan setara dhuwit awis perusahaan|Exagen Diagnostics (XGN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan MDXH|Dana dhuwit perusahaan Prenetics Global|Dana dhuwit perusahaan IMDX|Dhuwit awis perusahaan TRIB (Trinity Biotech PLC)|ProPhase Labs - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AIMD (Ainos, Inc.)|CODX: Dhuwit awis lan setara dhuwit awis perusahaan|HSCS: Dhuwit awis perusahaan|BMRA - Volume dana dhuwit perusahaan|CDIO: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Onconetix|Dhuwit awis perusahaan VRAX|Dana dhuwit perusahaan BJDX|Dhuwit awis perusahaan AWH (aspirawh.com)|Dhuwit awis perusahaan acceleratediagnostics.com AXDX|Volume dana dhuwit perusahaan CNTG (CENTOGENE N.V.)|ENZ: Dhuwit awis lan setara dhuwit awis perusahaan|FRES (fresh2.co) - Cadangan dhuwit perusahaan|GENE (gtglabs.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ME: Volume dana dhuwit perusahaan|PMD - Aset likuid perusahaan